Tags

Type your tag names separated by a space and hit enter

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.
Nat Med. 2003 Mar; 9(3):352-5.NMed

Abstract

Nicotinic acid (niacin), a vitamin of the B complex, has been used for almost 50 years as a lipid-lowering drug. The pharmacological effect of nicotinic acid requires doses that are much higher than those provided by a normal diet. Its primary action is to decrease lipolysis in adipose tissue by inhibiting hormone-sensitive triglyceride lipase. This anti-lipolytic effect of nicotinic acid involves the inhibition of cyclic adenosine monophosphate (cAMP) accumulation in adipose tissue through a G(i)-protein-mediated inhibition of adenylyl cyclase. A G-protein-coupled receptor for nicotinic acid has been proposed in adipocytes. Here, we show that the orphan G-protein-coupled receptor, 'protein upregulated in macrophages by interferon-gamma' (mouse PUMA-G, human HM74), is highly expressed in adipose tissue and is a nicotinic acid receptor. Binding of nicotinic acid to PUMA-G or HM74 results in a G(i)-mediated decrease in cAMP levels. In mice lacking PUMA-G, the nicotinic acid-induced decrease in free fatty acid (FFA) and triglyceride plasma levels was abrogated, indicating that PUMA-G mediates the anti-lipolytic and lipid-lowering effects of nicotinic acid in vivo. The identification of the nicotinic acid receptor may be useful in the development of new drugs to treat dyslipidemia.

Authors+Show Affiliations

Institute of Pharmacology, University of Heidelberg, Heidelberg, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12563315

Citation

Tunaru, Sorin, et al. "PUMA-G and HM74 Are Receptors for Nicotinic Acid and Mediate Its Anti-lipolytic Effect." Nature Medicine, vol. 9, no. 3, 2003, pp. 352-5.
Tunaru S, Kero J, Schaub A, et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med. 2003;9(3):352-5.
Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., & Offermanns, S. (2003). PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nature Medicine, 9(3), 352-5.
Tunaru S, et al. PUMA-G and HM74 Are Receptors for Nicotinic Acid and Mediate Its Anti-lipolytic Effect. Nat Med. 2003;9(3):352-5. PubMed PMID: 12563315.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. AU - Tunaru,Sorin, AU - Kero,Jukka, AU - Schaub,Annette, AU - Wufka,Christian, AU - Blaukat,Andree, AU - Pfeffer,Klaus, AU - Offermanns,Stefan, Y1 - 2003/02/03/ PY - 2002/10/01/received PY - 2003/01/10/accepted PY - 2003/2/4/pubmed PY - 2003/5/13/medline PY - 2003/2/4/entrez SP - 352 EP - 5 JF - Nature medicine JO - Nat Med VL - 9 IS - 3 N2 - Nicotinic acid (niacin), a vitamin of the B complex, has been used for almost 50 years as a lipid-lowering drug. The pharmacological effect of nicotinic acid requires doses that are much higher than those provided by a normal diet. Its primary action is to decrease lipolysis in adipose tissue by inhibiting hormone-sensitive triglyceride lipase. This anti-lipolytic effect of nicotinic acid involves the inhibition of cyclic adenosine monophosphate (cAMP) accumulation in adipose tissue through a G(i)-protein-mediated inhibition of adenylyl cyclase. A G-protein-coupled receptor for nicotinic acid has been proposed in adipocytes. Here, we show that the orphan G-protein-coupled receptor, 'protein upregulated in macrophages by interferon-gamma' (mouse PUMA-G, human HM74), is highly expressed in adipose tissue and is a nicotinic acid receptor. Binding of nicotinic acid to PUMA-G or HM74 results in a G(i)-mediated decrease in cAMP levels. In mice lacking PUMA-G, the nicotinic acid-induced decrease in free fatty acid (FFA) and triglyceride plasma levels was abrogated, indicating that PUMA-G mediates the anti-lipolytic and lipid-lowering effects of nicotinic acid in vivo. The identification of the nicotinic acid receptor may be useful in the development of new drugs to treat dyslipidemia. SN - 1078-8956 UR - https://www.unboundmedicine.com/medline/citation/12563315/PUMA_G_and_HM74_are_receptors_for_nicotinic_acid_and_mediate_its_anti_lipolytic_effect_ L2 - https://doi.org/10.1038/nm824 DB - PRIME DP - Unbound Medicine ER -